Savvy Updates, 2/22/21: Dexcom Ventures, Printed Pancreases, Microplastics Pollution, Dr. Steve Edelman on Carbs vs. Calories
Dexcom unveils new corporate venture fund to invest in sensor, health monitoring startups was reported by Mike Freeman for SanDiegoUnionTribune.com, 12 February 2021. Dexcom, a maker of wearable continuous glucose monitors for people with diabetes, said Thursday...
Savvy Updates, 2/15/21: HARPA, Recharging Wearables, C-Peptide, D Neuropathic Pain
Meet HARPA, the bold way Biden can jump-start health innovation was published by Ruth Reader for FastCompany.com, 12 February 2021. The Biden administration is contemplating creating a research agency to help fund breakthroughs that aren’t economically viable for...
Savvy Updates, 2/8/21: New Cases of D linked to Covid-19, Insulin without Refrigeration, Vertex & Diabetes Drug Trial, Sweet Victory Gum, Burnout and Cortisol Sensor
New diabetes cases linked to covid-19 was reported by Erin Blakemore for TheWashingtonPost.com, 1 February 2021. Researchers don’t understand exactly how the disease might trigger Type 1 or Type 2 diabetes, or whether the cases are temporary or permanent. But 14...
Savvy Updates, 2/1/21: Zealand’s Glucagon, Alternative Milks, Sugars, Humor and Well-being at Stanford & Yale, Apple Watch 7 & BG,
Beyond Insulin: The Future of Dual Hormone Treatment was written by Lala Jackson for BeyondType1.org, 25 January 2021. While insulin is the hormone without which people would die, as it is required to convert food to fuel in the body, there are other...
Savvy Updates, 1/25/21: Immunotherapy to Cure T1D, Non-invasive CGM by Afon, New Insulin Molecule,
The beginning of the end for Type 1 diabetes: A new view from immunotherapy science was posted on OpenAccessGovernment.org, 16 December 2020. Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge...
More Diabetes Blogs